Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rifca Le Dieu

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Seminars in Oncology|April 18, 2006
Vaccine- and immune-based therapy in chronic lymphocytic leukemiaRifca Le Dieu, John Gribben
Journal of HIV Therapy|January 3, 2006
CD40 activation: lessons for HIV immunotherapy from malignancies?Rifca Le Dieu, John Gribben
Current Hematologic Malignancy Reports|April 29, 2010
Transplantation in chronic lymphocytic leukemiaRifca Le Dieu, John G Gribben
Journal of Immunological Methods|July 7, 2009
Negative immunomagnetic selection of T cells from peripheral blood of presentation AML specimensRifca Le Dieu, David Taussig, T Andrew Lister, et al.
Plos One|March 12, 2016
MicroRNAs hsa-miR-99b, hsa-miR-330, hsa-miR-126 and hsa-miR-30c: Potential Diagnostic Biomarkers in Natural Killer (NK) Cells of Patients with Chronic Fatigue Syndrome (CFS)/ Myalgic Encephalomyelitis (ME)Robert D Petty, Neil E McCarthy, Rifca Le Dieu, et al.
The Journal of Clinical Investigation|June 14, 2008
Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drugAlan G Ramsay, Amy J Johnson, Abigail M Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 2009
E(mu)-TCL1 mice represent a model for immunotherapeutic reversal of chronic lymphocytic leukemia-induced T-cell dysfunctionGullu Gorgun, Alan G Ramsay, Tobias A W Holderried, et al.
Blood|August 28, 2009
Peripheral blood T cells in acute myeloid leukemia (AML) patients at diagnosis have abnormal phenotype and genotype and form defective immune synapses with AML blastsRifca Le Dieu, David C Taussig, Alan G Ramsay, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 5, 2011
EBMT risk score predicts outcome of allogeneic hematopoietic stem cell transplantation in patients who have failed a previous transplantation procedureKatayoun Rezvani, Edward J Kanfer, David Marin, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Seminars in Oncology|April 18, 2006
Vaccine- and immune-based therapy in chronic lymphocytic leukemiaRifca Le Dieu, John Gribben
Journal of HIV Therapy|January 3, 2006
CD40 activation: lessons for HIV immunotherapy from malignancies?Rifca Le Dieu, John Gribben
Current Hematologic Malignancy Reports|April 29, 2010
Transplantation in chronic lymphocytic leukemiaRifca Le Dieu, John G Gribben
Journal of Immunological Methods|July 7, 2009
Negative immunomagnetic selection of T cells from peripheral blood of presentation AML specimensRifca Le Dieu, David Taussig, T Andrew Lister, et al.
Plos One|March 12, 2016
MicroRNAs hsa-miR-99b, hsa-miR-330, hsa-miR-126 and hsa-miR-30c: Potential Diagnostic Biomarkers in Natural Killer (NK) Cells of Patients with Chronic Fatigue Syndrome (CFS)/ Myalgic Encephalomyelitis (ME)Robert D Petty, Neil E McCarthy, Rifca Le Dieu, et al.
The Journal of Clinical Investigation|June 14, 2008
Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drugAlan G Ramsay, Amy J Johnson, Abigail M Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 2009
E(mu)-TCL1 mice represent a model for immunotherapeutic reversal of chronic lymphocytic leukemia-induced T-cell dysfunctionGullu Gorgun, Alan G Ramsay, Tobias A W Holderried, et al.
Blood|August 28, 2009
Peripheral blood T cells in acute myeloid leukemia (AML) patients at diagnosis have abnormal phenotype and genotype and form defective immune synapses with AML blastsRifca Le Dieu, David C Taussig, Alan G Ramsay, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 5, 2011
EBMT risk score predicts outcome of allogeneic hematopoietic stem cell transplantation in patients who have failed a previous transplantation procedureKatayoun Rezvani, Edward J Kanfer, David Marin, et al.
Pageof 1